SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-014474
Filing Date
2024-04-12
Accepted
2024-04-12 17:00:42
Documents
46
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 819237
2 ex31-1.htm EX-31.1 13068
3 ex31-2.htm EX-31.2 11911
4 ex32-1.htm EX-32.1 6422
5 ex32-2.htm EX-32.2 6472
  Complete submission text file 0001493152-24-014474.txt   3803223

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bmra-20240229.xsd EX-101.SCH 21061
7 XBRL CALCULATION FILE bmra-20240229_cal.xml EX-101.CAL 44668
8 XBRL DEFINITION FILE bmra-20240229_def.xml EX-101.DEF 95100
9 XBRL LABEL FILE bmra-20240229_lab.xml EX-101.LAB 235304
10 XBRL PRESENTATION FILE bmra-20240229_pre.xml EX-101.PRE 176822
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 529370
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 24842204
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)